$CCAP
Crescent Capital BDC, Inc. Stock $ccap

$ccap Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000095017023003786 Filed on February 22, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$17.49M	$34.58M	$59.73M
YoY Change	-33.69%	43.23%	-36.45%
Cost Of Revenue	$20.69M	$18.64M	$59.97M
YoY Change	55.86%	83.82%	46.25%
Gross Profit	$18.59M	$15.93M	$56.74M
YoY Change	41.84%	13.82%	7.11%
Gross Profit Margin	106.26%	46.09%	95.0%
Selling, General & Admin	$894.0K	$810.0K	$3.184M
YoY Change	9.96%	21.62%	2.61%
% of Gross Profit	4.81%	5.08%	5.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$21.72M	-$262.0K	$57.60M
YoY Change	2571.96%	-139.34%	1756.27%
Operating Profit	-$21.59M	$16.20M	-$56.83M
YoY Change	-275.64%	21.47%	-213.95%
Interest Expense	-$9.715M	-$13.50M	-$44.19M
YoY Change	-338.58%	-1268.08%	-218.83%
% of Operating Profit		-83.37%
Other Income/Expense, Net
YoY Change
Pretax Income	$17.69M	$2.693M	$59.88M
YoY Change	8.13%	-80.32%	-30.27%
Income Tax	$201.0K	$91.00K	-$326.0K
% Of Pretax Income	1.14%	3.38%	-0.54%
Net Earnings	$7.777M	$2.602M	$15.54M
YoY Change	-52.02%	-79.73%	-81.41%
Net Earnings / Revenue	44.46%	7.53%	26.02%
Basic Earnings Per Share	$0.54		$1.93
Diluted Earnings Per Share	$0.54	$0.08	$1.93
COMMON SHARES
Basic Shares Outstanding	30.89M	30.89M	30.89M
Diluted Shares Outstanding	32.47M		30.89M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.45M	$6.397M	$6.397M
YoY Change	193.19%	-36.47%	-36.47%
Cash & Equivalents	$21.45M	$6.397M	$6.397M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$7.687M	$5.000K	$5.000K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$29.13M	$6.402M	$6.402M
YoY Change	266.42%	-74.33%	-74.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.566B	$1.263B	$1.263B
YoY Change	21.53%	-0.58%	-0.58%
Other Assets	$13.10M	$10.76M	$10.76M
YoY Change	19.99%	-20.28%	-20.28%
Total Long-Term Assets	$1.602B	$1.296B	$1.296B
YoY Change	22.34%	0.28%	0.28%
TOTAL ASSETS
Total Short-Term Assets	$29.13M	$6.402M	$6.402M
Total Long-Term Assets	$1.602B	$1.296B	$1.296B
Total Assets	$1.631B	$1.303B	$1.303B
YoY Change	23.81%	-1.13%	-1.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.410M	$4.570M	$4.570M
YoY Change	11.39%	19.32%	19.32%
Accrued Expenses	$11.91M	$14.33M	$14.33M
YoY Change	110.26%	53.0%	53.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$35.28M	$34.83M	$34.83M
YoY Change	9.84%	5.86%	5.86%
LONG-TERM LIABILITIES
Long-Term Debt	$875.8M	$654.5M	$654.5M
YoY Change	39.21%	3.71%	3.71%
Other Long-Term Liabilities	$173.0K	$157.0K	$157.0K
YoY Change	-85.31%	-75.12%	-75.12%
Total Long-Term Liabilities	$876.0M	$654.6M	$654.6M
YoY Change	38.97%	3.63%	3.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.28M	$34.83M	$34.83M
Total Long-Term Liabilities	$876.0M	$654.6M	$654.6M
Total Liabilities	$912.7M	$690.3M	$690.3M
YoY Change	37.63%	3.73%	3.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$69.92M	-$62.50M
YoY Change		349.37%
Common Stock	$37.00K	$675.0M
YoY Change		1.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$718.4M	$612.5M	$612.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.631B	$1.303B	$1.303B
YoY Change	23.81%	-1.13%	-1.13%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$7.777M	$2.602M	$15.54M
YoY Change	-52.02%	-79.73%	-81.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$16.01M	$41.85M	$27.95M
YoY Change	43.35%	-136.78%	-117.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid	$12.66M		$55.29M
YoY Change	-10.87%		15.84%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.399M	-46.93M	-34.41M
YoY Change	-108.45%	-139.84%	-120.69%
NET CHANGE
Cash From Operating Activities	16.01M	41.85M	27.95M
Cash From Investing Activities
Cash From Financing Activities	1.399M	-46.93M	-34.41M
Net Change In Cash	17.41M	-5.081M	-6.459M
YoY Change	-423.47%	-226.99%	-174.52%
FREE CASH FLOW
Cash From Operating Activities	$16.01M	$41.85M	$27.95M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	814-01132
CY2022	dei	Entity Registrant Name EntityRegistrantName	Crescent Capital BDC, Inc.
CY2021	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#GainLossOnInvestments
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001633336
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#GainLossOnInvestments
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3162282
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	11100 Santa Monica Blvd
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2000
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90025
CY2022	dei	City Area Code CityAreaCode	310
CY2022	dei	Local Phone Number LocalPhoneNumber	235-5900
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	CCAP
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	225600000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30887360
CY2022	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022Q4	ccap	Non Controlled Non Affiliated Investments At Cost NonControlledNonAffiliatedInvestmentsAtCost	1235778000
CY2021Q4	ccap	Non Controlled Non Affiliated Investments At Cost NonControlledNonAffiliatedInvestmentsAtCost	1150173000
CY2022Q4	ccap	Non Controlled Non Affiliated Investments NonControlledNonAffiliatedInvestments	1208501000
CY2021Q4	ccap	Non Controlled Non Affiliated Investments NonControlledNonAffiliatedInvestments	1165897000
CY2022Q4	ccap	Non Controlled Affiliated Investment At Cost NonControlledAffiliatedInvestmentAtCost	42040000
CY2021Q4	ccap	Non Controlled Affiliated Investment At Cost NonControlledAffiliatedInvestmentAtCost	41242000
CY2022Q4	ccap	Non Controlled Affiliated Investments NonControlledAffiliatedInvestments	43080000
CY2021Q4	ccap	Non Controlled Affiliated Investments NonControlledAffiliatedInvestments	51701000
CY2022Q4	ccap	Controlled Investments At Cost ControlledInvestmentsAtCost	13638000
CY2021Q4	ccap	Controlled Investments At Cost ControlledInvestmentsAtCost	53431000
CY2022Q4	ccap	Controlled Investments ControlledInvestments	11375000
CY2021Q4	ccap	Controlled Investments ControlledInvestments	52768000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6397000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10069000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10670000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	13457000
CY2022Q4	ccap	Interest And Dividend Receivable InterestAndDividendReceivable	9945000
CY2021Q4	ccap	Interest And Dividend Receivable InterestAndDividendReceivable	6763000
CY2022Q4	ccap	Unrealized Appreciation On Foreign Currency Forward Contracts UnrealizedAppreciationOnForeignCurrencyForwardContracts	8154000
CY2021Q4	ccap	Unrealized Appreciation On Foreign Currency Forward Contracts UnrealizedAppreciationOnForeignCurrencyForwardContracts	2115000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	91000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	42000
CY2022Q4	ccap	Receivable For Investments Sold ReceivableForInvestmentsSold	5000
CY2021Q4	ccap	Receivable For Investments Sold ReceivableForInvestmentsSold	14871000
CY2022Q4	us-gaap	Other Assets OtherAssets	4660000
CY2021Q4	us-gaap	Other Assets OtherAssets	126000
CY2022Q4	us-gaap	Assets Assets	1302878000
CY2021Q4	us-gaap	Assets Assets	1317809000
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5380000
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6897000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	654456000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	631040000
CY2022Q4	ccap	Distributions Payable DistributionsPayable	12664000
CY2021Q4	ccap	Distributions Payable DistributionsPayable	12664000
CY2022Q4	ccap	Interest And Other Debt Financing Costs Payable InterestAndOtherDebtFinancingCostsPayable	8471000
CY2021Q4	ccap	Interest And Other Debt Financing Costs Payable InterestAndOtherDebtFinancingCostsPayable	5513000
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	4056000
CY2021Q4	us-gaap	Management Fee Payable ManagementFeePayable	3830000
CY2022Q4	ccap	Incentive Fees Payable IncentiveFeesPayable	3112000
CY2021Q4	ccap	Incentive Fees Payable IncentiveFeesPayable	6924000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	899000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	956000
CY2022Q4	ccap	Payable For Investment Purchased PayableForInvestmentPurchased	514000
CY2022Q4	ccap	Directors Fees Payable DirectorsFeesPayable	151000
CY2021Q4	ccap	Directors Fees Payable DirectorsFeesPayable	114000
CY2022Q4	ccap	Unrealized Depreciation On Foreign Currency Forward Contracts UnrealizedDepreciationOnForeignCurrencyForwardContracts	157000
CY2021Q4	ccap	Unrealized Depreciation On Foreign Currency Forward Contracts UnrealizedDepreciationOnForeignCurrencyForwardContracts	631000
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	5857000
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3852000
CY2022Q4	us-gaap	Liabilities Liabilities	690337000
CY2021Q4	us-gaap	Liabilities Liabilities	665524000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30887360
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30887360
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30887360
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30887360
CY2020	us-gaap	Sponsor Fees SponsorFees	11438000
CY2022	ccap	Income Based Incentive Fees IncomeBasedIncentiveFees	11214000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	31000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	31000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	675008000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	666162000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62498000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13908000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	612541000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	652285000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1302878000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1317809000
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	19.83
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	21.12
CY2022	ccap	Interest Income Non Controlled Non Affiliated Investments InterestIncomeNonControlledNonAffiliatedInvestments	101751000
CY2021	ccap	Interest Income Non Controlled Non Affiliated Investments InterestIncomeNonControlledNonAffiliatedInvestments	81371000
CY2020	ccap	Interest Income Non Controlled Non Affiliated Investments InterestIncomeNonControlledNonAffiliatedInvestments	66078000
CY2022	ccap	Paid In Kind Interest Non Controlled Non Affiliated Investments PaidInKindInterestNonControlledNonAffiliatedInvestments	1564000
CY2021	ccap	Paid In Kind Interest Non Controlled Non Affiliated Investments PaidInKindInterestNonControlledNonAffiliatedInvestments	1881000
CY2020	ccap	Paid In Kind Interest Non Controlled Non Affiliated Investments PaidInKindInterestNonControlledNonAffiliatedInvestments	2169000
CY2022	ccap	Dividend Income Non Controlled Non Affiliated Investments DividendIncomeNonControlledNonAffiliatedInvestments	127000
CY2021	ccap	Dividend Income Non Controlled Non Affiliated Investments DividendIncomeNonControlledNonAffiliatedInvestments	1919000
CY2020	ccap	Dividend Income Non Controlled Non Affiliated Investments DividendIncomeNonControlledNonAffiliatedInvestments	323000
CY2022	ccap	Other Income Non Controlled Non Affiliated Investments OtherIncomeNonControlledNonAffiliatedInvestments	540000
CY2021	ccap	Other Income Non Controlled Non Affiliated Investments OtherIncomeNonControlledNonAffiliatedInvestments	791000
CY2020	ccap	Other Income Non Controlled Non Affiliated Investments OtherIncomeNonControlledNonAffiliatedInvestments	1060000
CY2022	ccap	Interest Income Non Controlled Affiliated Investments InterestIncomeNonControlledAffiliatedInvestments	1625000
CY2021	ccap	Interest Income Non Controlled Affiliated Investments InterestIncomeNonControlledAffiliatedInvestments	1170000
CY2020	ccap	Interest Income Non Controlled Affiliated Investments InterestIncomeNonControlledAffiliatedInvestments	1420000
CY2022	ccap	Paid In Kind Interest Non Controlled Affiliated Investments PaidInKindInterestNonControlledAffiliatedInvestments	2106000
CY2021	ccap	Paid In Kind Interest Non Controlled Affiliated Investments PaidInKindInterestNonControlledAffiliatedInvestments	1235000
CY2020	ccap	Paid In Kind Interest Non Controlled Affiliated Investments PaidInKindInterestNonControlledAffiliatedInvestments	1456000
CY2022	ccap	Dividend Income Non Controlled Affiliated Investments DividendIncomeNonControlledAffiliatedInvestments	5169000
CY2021	ccap	Dividend Income Non Controlled Affiliated Investments DividendIncomeNonControlledAffiliatedInvestments	2414000
CY2020	ccap	Dividend Income Non Controlled Affiliated Investments DividendIncomeNonControlledAffiliatedInvestments	2407000
CY2021	ccap	Other Income Non Controlled Affiliated Investments OtherIncomeNonControlledAffiliatedInvestments	3000
CY2022	ccap	Interest Income Controlled Investments InterestIncomeControlledInvestments	745000
CY2021	ccap	Interest Income Controlled Investments InterestIncomeControlledInvestments	2000
CY2022	ccap	Paid In Kind Interest Controlled Investments PaidInKindInterestControlledInvestments	732000
CY2022	ccap	Dividend Income Controlled Investments DividendIncomeControlledInvestments	2358000
CY2021	ccap	Dividend Income Controlled Investments DividendIncomeControlledInvestments	3200000
CY2020	ccap	Dividend Income Controlled Investments DividendIncomeControlledInvestments	2200000
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	116717000
CY2021	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	93986000
CY2020	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	77113000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	31880000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	19766000
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	15485000
CY2021	ccap	Income Based Incentive Fees IncomeBasedIncentiveFees	9849000
CY2020	ccap	Income Based Incentive Fees IncomeBasedIncentiveFees	8639000
CY2022	ccap	Capital Gains Based Incentive Fees CapitalGainsBasedIncentiveFees	-6324000
CY2021	ccap	Capital Gains Based Incentive Fees CapitalGainsBasedIncentiveFees	6324000
CY2022	us-gaap	Sponsor Fees SponsorFees	16344000
CY2021	us-gaap	Sponsor Fees SponsorFees	14118000
CY2022	us-gaap	Professional Fees ProfessionalFees	1302000
CY2021	us-gaap	Professional Fees ProfessionalFees	1769000
CY2020	us-gaap	Professional Fees ProfessionalFees	1460000
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	524000
CY2021	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	475000
CY2020	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	437000
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2660000
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2628000
CY2020	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2544000
CY2022	us-gaap	Operating Expenses OperatingExpenses	57600000
CY2021	us-gaap	Operating Expenses OperatingExpenses	54929000
CY2020	us-gaap	Operating Expenses OperatingExpenses	40003000
CY2022	ccap	Management Fees Waiver ManagementFeesWaiver	229000
CY2021	ccap	Management Fees Waiver ManagementFeesWaiver	3302000
CY2020	ccap	Management Fees Waiver ManagementFeesWaiver	4672000
CY2022	ccap	Income Based Incentive Fees Waiver IncomeBasedIncentiveFeesWaiver	538000
CY2021	ccap	Income Based Incentive Fees Waiver IncomeBasedIncentiveFeesWaiver	7517000
CY2020	ccap	Income Based Incentive Fees Waiver IncomeBasedIncentiveFeesWaiver	8639000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-56833000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-44110000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-26692000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	59884000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	49876000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	50421000
CY2022	ccap	Income And Excise Taxes IncomeAndExciseTaxes	155000
CY2021	ccap	Income And Excise Taxes IncomeAndExciseTaxes	2250000
CY2020	ccap	Income And Excise Taxes IncomeAndExciseTaxes	541000
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	59729000
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	47626000
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	49880000
CY2022	ccap	Net Realized Gain Loss On Non Controlled Non Affiliated Investments NetRealizedGainLossOnNonControlledNonAffiliatedInvestments	1157000
CY2021	ccap	Net Realized Gain Loss On Non Controlled Non Affiliated Investments NetRealizedGainLossOnNonControlledNonAffiliatedInvestments	3687000
CY2020	ccap	Net Realized Gain Loss On Non Controlled Non Affiliated Investments NetRealizedGainLossOnNonControlledNonAffiliatedInvestments	-10889000
CY2022	ccap	Net Realized Gain Loss On Non Controlled Affiliated Investments NetRealizedGainLossOnNonControlledAffiliatedInvestments	7098000
CY2021	ccap	Net Realized Gain Loss On Non Controlled Affiliated Investments NetRealizedGainLossOnNonControlledAffiliatedInvestments	28810000
CY2020	ccap	Net Realized Gain Loss On Non Controlled Affiliated Investments NetRealizedGainLossOnNonControlledAffiliatedInvestments	-4314000
CY2022	ccap	Net Realized Gain Loss On Controlled Investments NetRealizedGainLossOnControlledInvestments	-3301000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-33000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	311000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-83000
CY2022	ccap	Net Realized Gain Loss On Foreign Currency Forward Contracts NetRealizedGainLossOnForeignCurrencyForwardContracts	24000
CY2021	ccap	Net Realized Gain Loss On Foreign Currency Forward Contracts NetRealizedGainLossOnForeignCurrencyForwardContracts	-193000
CY2022	ccap	Net Change In Unrealized Appreciation Depreciation On Non Controlled Non Affiliated Investments And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnNonControlledNonAffiliatedInvestmentsAndForeignCurrencyTranslation	-43818000
CY2021	ccap	Net Change In Unrealized Appreciation Depreciation On Non Controlled Non Affiliated Investments And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnNonControlledNonAffiliatedInvestmentsAndForeignCurrencyTranslation	12535000
CY2020	ccap	Net Change In Unrealized Appreciation Depreciation On Non Controlled Non Affiliated Investments And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnNonControlledNonAffiliatedInvestmentsAndForeignCurrencyTranslation	7437000
CY2022	ccap	Net Change In Unrealized Appreciation Depreciation On Non Controlled Affiliated Investments NetChangeInUnrealizedAppreciationDepreciationOnNonControlledAffiliatedInvestments	-9419000
CY2021	ccap	Net Change In Unrealized Appreciation Depreciation On Non Controlled Affiliated Investments NetChangeInUnrealizedAppreciationDepreciationOnNonControlledAffiliatedInvestments	-10464000
CY2020	ccap	Net Change In Unrealized Appreciation Depreciation On Non Controlled Affiliated Investments NetChangeInUnrealizedAppreciationDepreciationOnNonControlledAffiliatedInvestments	19686000
CY2022	ccap	Net Change In Unrealized Appreciation Depreciation On Controlled Investments NetChangeInUnrealizedAppreciationDepreciationOnControlledInvestments	-1600000
CY2021	ccap	Net Change In Unrealized Appreciation Depreciation On Controlled Investments NetChangeInUnrealizedAppreciationDepreciationOnControlledInvestments	602000
CY2020	ccap	Net Change In Unrealized Appreciation Depreciation On Controlled Investments NetChangeInUnrealizedAppreciationDepreciationOnControlledInvestments	-1707000
CY2022	ccap	Net Change In Unrealized Appreciation Depreciation On Foreign Currency Forward Contracts NetChangeInUnrealizedAppreciationDepreciationOnForeignCurrencyForwardContracts	6513000
CY2020	ccap	Net Change In Unrealized Appreciation Depreciation On Foreign Currency Forward Contracts NetChangeInUnrealizedAppreciationDepreciationOnForeignCurrencyForwardContracts	-1324000
CY2021	ccap	Net Change In Unrealized Appreciation Depreciation On Foreign Currency Forward Contracts NetChangeInUnrealizedAppreciationDepreciationOnForeignCurrencyForwardContracts	2116000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-43379000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	37404000
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	8806000
CY2020	ccap	Realized Loss On Asset Acquisition RealizedLossOnAssetAcquisition	3825000
CY2022	ccap	Net Realized And Unrealized Gains Losses On Investments And Asset Acquisition NetRealizedAndUnrealizedGainsLossesOnInvestmentsAndAssetAcquisition	-43379000
CY2021	ccap	Net Realized And Unrealized Gains Losses On Investments And Asset Acquisition NetRealizedAndUnrealizedGainsLossesOnInvestmentsAndAssetAcquisition	37404000
CY2020	ccap	Net Realized And Unrealized Gains Losses On Investments And Asset Acquisition NetRealizedAndUnrealizedGainsLossesOnInvestmentsAndAssetAcquisition	4981000
CY2022	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	-911000
CY2021	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	-1177000
CY2020	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	46000
CY2022	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	105000
CY2021	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	-220000
CY2020	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	-235000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15544000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	83633000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	54672000
CY2022	ccap	Net Increase Decrease In Net Assets Resulting From Operations Per Share Basic And Diluted NetIncreaseDecreaseInNetAssetsResultingFromOperationsPerShareBasicAndDiluted	0.50
CY2021	ccap	Net Increase Decrease In Net Assets Resulting From Operations Per Share Basic And Diluted NetIncreaseDecreaseInNetAssetsResultingFromOperationsPerShareBasicAndDiluted	2.94
CY2020	ccap	Net Increase Decrease In Net Assets Resulting From Operations Per Share Basic And Diluted NetIncreaseDecreaseInNetAssetsResultingFromOperationsPerShareBasicAndDiluted	1.98
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.93
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.93
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.67
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.80
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30887360
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30887360
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28477771
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28477771
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27681757
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27681757
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	652285000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	59729000
CY2022	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	4945000
CY2022	ccap	Net Change In Unrealized Appreciation Depreciation On Investments Foreign Currency Forward Contracts And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsForeignCurrencyForwardContractsAndForeignCurrencyTranslation	-48324000
CY2022	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	-911000
CY2022	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	105000
CY2022	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	55288000
CY2022	us-gaap	Investment Company Net Assets Period Increase Decrease InvestmentCompanyNetAssetsPeriodIncreaseDecrease	612541000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	612541000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	560000000
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	47626000
CY2021	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	32615000
CY2021	ccap	Net Change In Unrealized Appreciation Depreciation On Investments Foreign Currency Forward Contracts And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsForeignCurrencyForwardContractsAndForeignCurrencyTranslation	4789000
CY2021	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	-1177000
CY2021	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	-220000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	52632000
CY2021	ccap	Increase Decrease In Receivable For Investments Sold IncreaseDecreaseInReceivableForInvestmentsSold	14865000
CY2021	ccap	Deemed Contribution From The Advisor DeemedContributionFromTheAdvisor	5386000
CY2021	ccap	Investment Company Equity Offering Costs InvestmentCompanyEquityOfferingCosts	523000
CY2021	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	48843000
CY2021	us-gaap	Investment Company Net Assets Period Increase Decrease InvestmentCompanyNetAssetsPeriodIncreaseDecrease	92285000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	652285000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	406917000
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	49880000
CY2020	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-15286000
CY2020	ccap	Net Change In Unrealized Appreciation Depreciation On Investments Foreign Currency Forward Contracts And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsForeignCurrencyForwardContractsAndForeignCurrencyTranslation	24092000
CY2020	ccap	Realized Loss On Asset Acquisition RealizedLossOnAssetAcquisition	3825000
CY2020	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	46000
CY2020	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	-235000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44297000
CY2020	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	101949000
CY2020	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	589000
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2208000
CY2020	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	46216000
CY2020	us-gaap	Investment Company Net Assets Period Increase Decrease InvestmentCompanyNetAssetsPeriodIncreaseDecrease	153083000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	560000000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15544000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	83633000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	54672000
CY2022	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	307998000
CY2021	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	647376000
CY2020	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	352392000
CY2022	us-gaap-supplement	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	4455000
CY2021	us-gaap-supplement	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	3148000
CY2020	us-gaap-supplement	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	3625000
CY2022	ccap	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	277566000
CY2021	ccap	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	461268000
CY2020	ccap	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	258979000
CY2022	ccap	Foreign Currency Transactions And Forward Contracts Realized Gain Loss On Investments ForeignCurrencyTransactionsAndForwardContractsRealizedGainLossOnInvestments	4886000
CY2021	ccap	Foreign Currency Transactions And Forward Contracts Realized Gain Loss On Investments ForeignCurrencyTransactionsAndForwardContractsRealizedGainLossOnInvestments	33162000
CY2020	ccap	Foreign Currency Transactions And Forward Contracts Realized Gain Loss On Investments ForeignCurrencyTransactionsAndForwardContractsRealizedGainLossOnInvestments	-15786000
CY2020	ccap	Realized Loss On Asset Acquisition RealizedLossOnAssetAcquisition	3825000
CY2020	ccap	Net Of Cash Acquired Upon Acquisition NetOfCashAcquiredUponAcquisition	12884000
CY2022	ccap	Net Change In Unrealized Appreciation Depreciation On Investments And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsAndForeignCurrencyTranslation	-54837000
CY2021	ccap	Net Change In Unrealized Appreciation Depreciation On Investments And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsAndForeignCurrencyTranslation	2673000
CY2020	ccap	Net Change In Unrealized Appreciation Depreciation On Investments And Foreign Currency Translation NetChangeInUnrealizedAppreciationDepreciationOnInvestmentsAndForeignCurrencyTranslation	25416000
CY2022	ccap	Net Change In Unrealized Appreciation Depreciation On Foreign Currency Forward Contracts NetChangeInUnrealizedAppreciationDepreciationOnForeignCurrencyForwardContracts	6513000
CY2021	ccap	Net Change In Unrealized Appreciation Depreciation On Foreign Currency Forward Contracts NetChangeInUnrealizedAppreciationDepreciationOnForeignCurrencyForwardContracts	2116000
CY2020	ccap	Net Change In Unrealized Appreciation Depreciation On Foreign Currency Forward Contracts NetChangeInUnrealizedAppreciationDepreciationOnForeignCurrencyForwardContracts	-1324000
CY2022	ccap	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	-6854000
CY2021	ccap	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	-11284000
CY2020	ccap	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	-5109000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1738000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2554000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1329000
CY2022	ccap	Increase Decrease In Receivable For Investments Sold IncreaseDecreaseInReceivableForInvestmentsSold	-14866000
CY2020	ccap	Increase Decrease In Receivable For Investments Sold IncreaseDecreaseInReceivableForInvestmentsSold	-549000
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	3182000
CY2021	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	135000000
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2904000
CY2020	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	25000
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	49000
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-588000
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	209000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4534000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-417000
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2480000
CY2022	ccap	Increase Decrease In Management Fees Payable IncreaseDecreaseInManagementFeesPayable	226000
CY2021	ccap	Increase Decrease In Management Fees Payable IncreaseDecreaseInManagementFeesPayable	1963000
CY2020	ccap	Increase Decrease In Management Fees Payable IncreaseDecreaseInManagementFeesPayable	524000
CY2022	ccap	Increase Decrease In Incentive Fees Payable IncreaseDecreaseInIncentiveFeesPayable	-3812000
CY2021	ccap	Increase Decrease In Incentive Fees Payable IncreaseDecreaseInIncentiveFeesPayable	6924000
CY2022	ccap	Increase Decrease In Directors Fees Payable IncreaseDecreaseInDirectorsFeesPayable	37000
CY2021	ccap	Increase Decrease In Directors Fees Payable IncreaseDecreaseInDirectorsFeesPayable	16000
CY2020	ccap	Increase Decrease In Directors Fees Payable IncreaseDecreaseInDirectorsFeesPayable	24000
CY2022	ccap	Increase Decrease In Interest And Other Debt Financing Costs Payable IncreaseDecreaseInInterestAndOtherDebtFinancingCostsPayable	2958000
CY2021	ccap	Increase Decrease In Interest And Other Debt Financing Costs Payable IncreaseDecreaseInInterestAndOtherDebtFinancingCostsPayable	1590000
CY2020	ccap	Increase Decrease In Interest And Other Debt Financing Costs Payable IncreaseDecreaseInInterestAndOtherDebtFinancingCostsPayable	-456000
CY2022	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-57000
CY2021	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-368000
CY2020	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	445000
CY2022	ccap	Increase Decrease In Payable For Investment Sold IncreaseDecreaseInPayableForInvestmentSold	514000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2005000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1289000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1620000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27951000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-157654000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-61799000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	52632000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	44297000
CY2021	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	5386000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2208000
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	221000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4851000
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2498000
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	55288000
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	47728000
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	42632000
CY2021	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	523000
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	339215000
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	654974000
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	352342000
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	318111000
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	612151000
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	302227000
CY2020	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	50000000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	16418000
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	33853000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-34405000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	166321000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63221000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-5000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6459000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8677000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1422000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23526000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14849000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13427000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17067000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23526000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14849000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	26903000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	15474000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	14489000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1974000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2176000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	692000
CY2020	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	589000
CY2022	ccap	Accrued But Unpaid Distributions AccruedButUnpaidDistributions	12664000
CY2021	ccap	Accrued But Unpaid Distributions AccruedButUnpaidDistributions	12664000
CY2020	ccap	Accrued But Unpaid Distributions AccruedButUnpaidDistributions	11549000
CY2020	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	101949000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6397000
CY2022Q4	ccap	Cash And Cash Equivalents Including Cash Denominated In Foreign Currency CashAndCashEquivalentsIncludingCashDenominatedInForeignCurrency	125000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10670000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10069000
CY2021Q4	ccap	Cash And Cash Equivalents Including Cash Denominated In Foreign Currency CashAndCashEquivalentsIncludingCashDenominatedInForeignCurrency	1064000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	13457000
CY2021Q4	ccap	Restricted Cash And Cash Equivalents Including Cash Denominated In Foreign Currency RestrictedCashAndCashEquivalentsIncludingCashDenominatedInForeignCurrency	743000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1746000
CY2020Q4	ccap	Cash And Cash Equivalents Including Cash Denominated In Foreign Currency CashAndCashEquivalentsIncludingCashDenominatedInForeignCurrency	132000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	12953000
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1291456000
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	2.062
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1262956000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	612541000
CY2022Q4	ccap	Percentage Of Qualifying Assets To Total Assets PercentageOfQualifyingAssetsToTotalAssets	0.70
CY2022Q4	ccap	Percentage Of Non Qualifying Assets On Fair Value PercentageOfNonQualifyingAssetsOnFairValue	0.171
CY2021Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1244846000
CY2021Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1.948
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1270366000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	652285000
CY2021Q4	ccap	Percentage Of Qualifying Assets To Total Assets PercentageOfQualifyingAssetsToTotalAssets	0.70
CY2021Q4	ccap	Percentage Of Non Qualifying Assets On Fair Value PercentageOfNonQualifyingAssetsOnFairValue	0.161
CY2021Q4	ccap	Number Of Portfolio Segments NumberOfPortfolioSegments	3
CY2022Q4	ccap	Number Of Investment Positions On Non Accrual Status NumberOfInvestmentPositionsOnNonAccrualStatus	6
CY2022Q4	ccap	Number Of Investment Positions On Non Accrual Status NumberOfInvestmentPositionsOnNonAccrualStatus	4
CY2022Q4	ccap	Percentage Of Net Debt Instrument At Cost PercentageOfNetDebtInstrumentAtCost	0.020
CY2022Q4	ccap	Percentage Of Net Debt Instrument At Fair Value PercentageOfNetDebtInstrumentAtFairValue	0.012
CY2021Q4	ccap	Number Of Investments On Non Accrual Status NumberOfInvestmentsOnNonAccrualStatus	5
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that may affect the amounts reported in the consolidated financial statements and accompanying notes. These consolidated financial statements reflect adjustments that in the opinion of management are necessary for the fair statement of the results for the periods presented. Although management believes that the estimates and assumptions are reasonable, changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2021Q4	ccap	Percentage Of Net Debt Instrument At Cost PercentageOfNetDebtInstrumentAtCost	0.016
CY2021Q4	ccap	Percentage Of Net Debt Instrument At Fair Value PercentageOfNetDebtInstrumentAtFairValue	0.012
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	In order for the Company not to be subject to federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its ordinary income (taking into account certain deferrals and elections), (ii) 98.2% of its net capital gains from the current year and (iii) any undistributed ordinary income and net capital gains from preceding years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% excise tax on this income.
CY2022	ccap	Administrative Services Expenses AdministrativeServicesExpenses	1316000
CY2021	ccap	Administrative Services Expenses AdministrativeServicesExpenses	1028000
CY2020	ccap	Administrative Services Expenses AdministrativeServicesExpenses	819000
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	511000
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	354000
CY2022	ccap	Annual Base Management Fee In Percentage Of Gross Assets AnnualBaseManagementFeeInPercentageOfGrossAssets	0.0125
CY2022	us-gaap	Management Fee Description ManagementFeeDescription	Under the terms of the Investment Advisory Agreement, the Adviser agreed to waive a portion of the management fee from February 1, 2020 through July 31, 2021 after the closing of the Alcentra Acquisition so that only 0.75% was charged for such time period.
CY2020Q1	ccap	Annual Base Management Fee In Percentage Of Gross Assets AnnualBaseManagementFeeInPercentageOfGrossAssets	0.0150
CY2022	ccap	Waived Portion Of Management Fee Percentage Aggregate Committed But Undrawn Capital WaivedPortionOfManagementFeePercentageAggregateCommittedButUndrawnCapital	0.0025
CY2022	ccap	Waived Portion Of Management Fee Percentage Of Aggregate Gross Assets Excluding Cash And Cash Equivalents WaivedPortionOfManagementFeePercentageOfAggregateGrossAssetsExcludingCashAndCashEquivalents	0.0075
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	16344000
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	14118000
CY2020	us-gaap	Management Fee Expense ManagementFeeExpense	11438000
CY2022	ccap	Management Fees Waiver ManagementFeesWaiver	229000
CY2021	ccap	Management Fees Waiver ManagementFeesWaiver	3302000
CY2020	ccap	Management Fees Waiver ManagementFeesWaiver	4672000
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	4056000
CY2021Q4	us-gaap	Management Fee Payable ManagementFeePayable	3830000
CY2022	ccap	Income Incentive Fee Percent Payable Quarterly In Excess Of Pre Incentive Fee Net Investment Income IncomeIncentiveFeePercentPayableQuarterlyInExcessOfPreIncentiveFeeNetInvestmentIncome	1
CY2022	ccap	Income Incentive Fee Quarterly Return On Investment Income Percent IncomeIncentiveFeeQuarterlyReturnOnInvestmentIncomePercent	0.0175
CY2020Q1	ccap	Income Incentive Fee Quarterly Return On Investment Income Percent IncomeIncentiveFeeQuarterlyReturnOnInvestmentIncomePercent	0.0150
CY2022	ccap	Income Incentive Fee Annual Return On Investment Income Percent IncomeIncentiveFeeAnnualReturnOnInvestmentIncomePercent	0.070
CY2020Q1	ccap	Income Incentive Fee Annual Return On Investment Income Percent IncomeIncentiveFeeAnnualReturnOnInvestmentIncomePercent	0.060
CY2022	ccap	Percent Of Pre Incentive Fee Net Investment Income Received To Obtain Catch Up Feature PercentOfPreIncentiveFeeNetInvestmentIncomeReceivedToObtainCatchUpFeature	0.175
CY2020Q1	ccap	Percent Of Pre Incentive Fee Net Investment Income Received To Obtain Catch Up Feature PercentOfPreIncentiveFeeNetInvestmentIncomeReceivedToObtainCatchUpFeature	0.150
CY2022	ccap	Pre Incentive Fee Net Investment Income Percent Threshold PreIncentiveFeeNetInvestmentIncomePercentThreshold	0.021212
CY2020Q1	ccap	Pre Incentive Fee Net Investment Income Percent Threshold PreIncentiveFeeNetInvestmentIncomePercentThreshold	0.017647
CY2022	ccap	Pre Incentive Fee Net Investment Income Percent In Excess Of Threshold PreIncentiveFeeNetInvestmentIncomePercentInExcessOfThreshold	0.175
CY2020Q1	ccap	Pre Incentive Fee Net Investment Income Percent In Excess Of Threshold PreIncentiveFeeNetInvestmentIncomePercentInExcessOfThreshold	0.150
CY2022	ccap	Capital Gains Incentive Fee Percent Payable Annually CapitalGainsIncentiveFeePercentPayableAnnually	0.175
CY2022	ccap	Income Incentive Fee Quarterly Return On Investment Income Percent IncomeIncentiveFeeQuarterlyReturnOnInvestmentIncomePercent	0.0175
CY2022	ccap	Income Incentive Fee Annual Return On Investment Income Percent IncomeIncentiveFeeAnnualReturnOnInvestmentIncomePercent	0.070
CY2020Q1	ccap	Income Incentive Fee Quarterly Return On Investment Income Percent IncomeIncentiveFeeQuarterlyReturnOnInvestmentIncomePercent	0.0150
CY2020Q1	ccap	Income Incentive Fee Annual Return On Investment Income Percent IncomeIncentiveFeeAnnualReturnOnInvestmentIncomePercent	0.060
CY2022	ccap	Income Based Incentive Fees IncomeBasedIncentiveFees	11214000
CY2021	ccap	Income Based Incentive Fees IncomeBasedIncentiveFees	9849000
CY2020	ccap	Income Based Incentive Fees IncomeBasedIncentiveFees	8639000
CY2022	ccap	Income Based Incentive Fees Waiver IncomeBasedIncentiveFeesWaiver	538000
CY2021	ccap	Income Based Incentive Fees Waiver IncomeBasedIncentiveFeesWaiver	7517000
CY2020	ccap	Income Based Incentive Fees Waiver IncomeBasedIncentiveFeesWaiver	8639000
CY2022	ccap	Income Based Incentive Fees Unpaid IncomeBasedIncentiveFeesUnpaid	3112000
CY2021	ccap	Income Based Incentive Fees Unpaid IncomeBasedIncentiveFeesUnpaid	600000
CY2022	ccap	Incentive Fee On Cumulative Unrealized Capital Appreciation Description IncentiveFeeOnCumulativeUnrealizedCapitalAppreciationDescription	This accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital appreciation or depreciation. If such amount is positive at the end of a period, then the Company records a capital gains incentive fee equal to 17.5% (15% prior to February 1, 2020) of such amount, minus the aggregate amount of actual incentive fees based on capital gains paid in all prior periods. If such amount is negative, then there is no accrual for such period. There can be no assurance that such unrealized capital appreciation will be realized in the future
CY2022	ccap	Capital Gains Incentive Fee Percent Payable Annually CapitalGainsIncentiveFeePercentPayableAnnually	0.175
CY2020Q1	ccap	Capital Gains Incentive Fee Percent Payable Annually CapitalGainsIncentiveFeePercentPayableAnnually	0.15
CY2022	ccap	Reversal Of Capital Gains Incentive Fees On Unrealized Capital Appreciation ReversalOfCapitalGainsIncentiveFeesOnUnrealizedCapitalAppreciation	-6324000
CY2021	ccap	Reversal Of Capital Gains Incentive Fees On Unrealized Capital Appreciation ReversalOfCapitalGainsIncentiveFeesOnUnrealizedCapitalAppreciation	6324000
CY2020	ccap	Reversal Of Capital Gains Incentive Fees On Unrealized Capital Appreciation ReversalOfCapitalGainsIncentiveFeesOnUnrealizedCapitalAppreciation	0
CY2022	ccap	Capital Gains Incentive Fees Accrued And Unpaid CapitalGainsIncentiveFeesAccruedAndUnpaid	0
CY2021	ccap	Capital Gains Incentive Fees Accrued And Unpaid CapitalGainsIncentiveFeesAccruedAndUnpaid	6324000
CY2022Q4	ccap	Percentage Of Outstanding Common Stock Owned PercentageOfOutstandingCommonStockOwned	0.0310
CY2021Q4	ccap	Percentage Of Outstanding Common Stock Owned PercentageOfOutstandingCommonStockOwned	0.0295
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	58018000
CY2021Q4	ccap	Transaction Support Provided By Adviser TransactionSupportProvidedByAdviser	5386000
CY2021Q4	ccap	Sales Load Payable To Underwriters SalesLoadPayableToUnderwriters	2105000
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1291456000
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1262956000
CY2022Q4	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	-28500000
CY2021Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1244846000
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1270366000
CY2021Q4	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	25520000
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1262956000
CY2022Q4	ccap	Investment Owned Percentage Of Fair Value InvestmentOwnedPercentageOfFairValue	1.000
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1270366000
CY2021Q4	ccap	Investment Owned Percentage Of Fair Value InvestmentOwnedPercentageOfFairValue	1.000
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1262956000
CY2022Q4	ccap	Investment Owned Percentage Of Fair Value InvestmentOwnedPercentageOfFairValue	1.000
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1270366000
CY2021Q4	ccap	Investment Owned Percentage Of Fair Value InvestmentOwnedPercentageOfFairValue	1.000
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1249196000
CY2022Q4	us-gaap	Alternative Investment AlternativeInvestment	13760000
CY2022Q4	us-gaap	Investments Investments	1262956000
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	8154000
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	157000
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1212406000
CY2021Q4	us-gaap	Alternative Investment AlternativeInvestment	57960000
CY2021Q4	us-gaap	Investments Investments	1270366000
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2115000
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	631000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1105680000
CY2022	ccap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Amortized Discounts Or Premiums FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAmortizedDiscountsOrPremiums	6561000
CY2022	ccap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Paid In Kind Interest FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaidInKindInterest	4455000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	8224000
CY2022	ccap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Net Change In Unrealized Appreciation Depreciation FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetNetChangeInUnrealizedAppreciationDepreciation	-49394000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	298215000
CY2022	ccap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales Return Of Capital Principal Repayments Paydowns FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSalesReturnOfCapitalPrincipalRepaymentsPaydowns	211562000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	36007000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	30199000
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1167987000
CY2022Q4	ccap	Fair Value Assets Measured On Recurring Basis Net Change In Unrealized Appreciation Depreciation From Investments Still Held FairValueAssetsMeasuredOnRecurringBasisNetChangeInUnrealizedAppreciationDepreciationFromInvestmentsStillHeld	-46892000
CY2022	ccap	Fair Value Assets Level3 To Level2 Transfers Amount FairValueAssetsLevel3ToLevel2TransfersAmount	30199000
CY2022	ccap	Fair Value Assets Level2 To Level3 Transfers Amount FairValueAssetsLevel2ToLevel3TransfersAmount	36007000
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	943877000
CY2021	ccap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Amortized Discounts Or Premiums FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAmortizedDiscountsOrPremiums	10989000
CY2021	ccap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Paid In Kind Interest FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaidInKindInterest	3148000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	33094000
CY2021	ccap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Net Change In Unrealized Appreciation Depreciation FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetNetChangeInUnrealizedAppreciationDepreciation	-1556000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	581506000
CY2021	ccap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales Return Of Capital Principal Repayments Paydowns FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSalesReturnOfCapitalPrincipalRepaymentsPaydowns	412277000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	1501000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	54602000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1105680000
CY2021Q4	ccap	Fair Value Assets Measured On Recurring Basis Net Change In Unrealized Appreciation Depreciation From Investments Still Held FairValueAssetsMeasuredOnRecurringBasisNetChangeInUnrealizedAppreciationDepreciationFromInvestmentsStillHeld	16937000
CY2021	ccap	Fair Value Assets Level3 To Level2 Transfers Amount FairValueAssetsLevel3ToLevel2TransfersAmount	54602000
CY2021	ccap	Fair Value Assets Level2 To Level3 Transfers Amount FairValueAssetsLevel2ToLevel3TransfersAmount	1501000
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	885000000
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	659836000
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	225164000
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	659836000
CY2021Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	835000000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	637937000
CY2021Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	197063000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	637937000
CY2022	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0473
CY2021	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0372
CY2020	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0368
CY2022	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	673503000
CY2021	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	530675000
CY2020	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	421066000
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	28930000
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	16166000
CY2020	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	13417000
CY2022	us-gaap	Debt Instrument Unused Borrowing Capacity Fee DebtInstrumentUnusedBorrowingCapacityFee	1212000
CY2021	us-gaap	Debt Instrument Unused Borrowing Capacity Fee DebtInstrumentUnusedBorrowingCapacityFee	1046000
CY2020	us-gaap	Debt Instrument Unused Borrowing Capacity Fee DebtInstrumentUnusedBorrowingCapacityFee	740000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1738000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2554000
CY2020	ccap	Amortization Of Financing Cost AmortizationOfFinancingCost	1328000
CY2022	ccap	Interest And Credit Facility Expenses InterestAndCreditFacilityExpenses	31880000
CY2021	ccap	Interest And Credit Facility Expenses InterestAndCreditFacilityExpenses	19766000
CY2020	ccap	Interest And Credit Facility Expenses InterestAndCreditFacilityExpenses	15485000
CY2022	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	673503000
CY2021	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	530675000
CY2020	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	421066000
CY2022Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0
CY2021Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	210000
CY2022	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	55288000
CY2021	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	48843000
CY2022Q4	us-gaap	Investment Company Financial Commitment To Investee Future Amount InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	158905000
CY2021Q4	us-gaap	Investment Company Financial Commitment To Investee Future Amount InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	195622000
CY2020	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	46216000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.838
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.867
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.980
CY2022Q4	ccap	Undistributed Net Investment Income On Tax Basis UndistributedNetInvestmentIncomeOnTaxBasis	15656000
CY2022Q4	us-gaap	Investment Company Financial Commitment To Investee Future Amount InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	158905000
CY2021Q4	us-gaap	Investment Company Financial Commitment To Investee Future Amount InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount	195622000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2720000
CY2021Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	58018000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15544000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	83633000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	54672000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30887360
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30887360
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28477771
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28477771
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27681757
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27681757
CY2022	ccap	Net Increase Decrease In Net Assets Resulting From Operations Per Share Basic And Diluted NetIncreaseDecreaseInNetAssetsResultingFromOperationsPerShareBasicAndDiluted	0.50
CY2021	ccap	Net Increase Decrease In Net Assets Resulting From Operations Per Share Basic And Diluted NetIncreaseDecreaseInNetAssetsResultingFromOperationsPerShareBasicAndDiluted	2.94
CY2020	ccap	Net Increase Decrease In Net Assets Resulting From Operations Per Share Basic And Diluted NetIncreaseDecreaseInNetAssetsResultingFromOperationsPerShareBasicAndDiluted	1.98
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	55288000
CY2021Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	48843000
CY2020Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	46216000
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss	0
CY2021Q4	ccap	Undistributed Net Investment Income On Tax Basis UndistributedNetInvestmentIncomeOnTaxBasis	13350000
CY2020Q4	ccap	Undistributed Net Investment Income On Tax Basis UndistributedNetInvestmentIncomeOnTaxBasis	8439000
CY2022Q4	ccap	Other Temporary Differences OtherTemporaryDifferences	-437000
CY2021Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss	0
CY2020Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss	0
CY2021Q4	ccap	Other Temporary Differences OtherTemporaryDifferences	-447000
CY2020Q4	ccap	Other Temporary Differences OtherTemporaryDifferences	-456000
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward	-41134000
CY2021Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward	-34248000
CY2020Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward	-63271000
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation	-36583000
CY2021Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation	7437000
CY2020Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation	20630000
CY2022Q4	us-gaap	Investment Company Distributable Earnings InvestmentCompanyDistributableEarnings	-62498000
CY2021Q4	us-gaap	Investment Company Distributable Earnings InvestmentCompanyDistributableEarnings	-13908000
CY2020Q4	us-gaap	Investment Company Distributable Earnings InvestmentCompanyDistributableEarnings	-34658000
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-5482000
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-16849000
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	35651000
CY2022	ccap	Distributions In Excess Of Investment Company Taxable Income DistributionsInExcessOfInvestmentCompanyTaxableIncome	-3364000
CY2021	ccap	Distributions In Excess Of Investment Company Taxable Income DistributionsInExcessOfInvestmentCompanyTaxableIncome	2837000
CY2020	ccap	Distributions In Excess Of Investment Company Taxable Income DistributionsInExcessOfInvestmentCompanyTaxableIncome	-94000
CY2022	ccap	Accumulated Net Realized Gain Loss And Distributions In Excess Of Investment Company Taxable Income AccumulatedNetRealizedGainLossAndDistributionsInExcessOfInvestmentCompanyTaxableIncome	-8846000
CY2021	ccap	Accumulated Net Realized Gain Loss And Distributions In Excess Of Investment Company Taxable Income AccumulatedNetRealizedGainLossAndDistributionsInExcessOfInvestmentCompanyTaxableIncome	-14012000
CY2020	ccap	Accumulated Net Realized Gain Loss And Distributions In Excess Of Investment Company Taxable Income AccumulatedNetRealizedGainLossAndDistributionsInExcessOfInvestmentCompanyTaxableIncome	-35745000
CY2022Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	1295847000
CY2021Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	1260862000
CY2022Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	9274000
CY2021Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	34877000
CY2022Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	42164000
CY2021Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	25373000
CY2022Q4	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	-32890000
CY2021Q4	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	9504000
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	19.50
CY2018Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	19.43
CY2017Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	20.10
CY2022	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.93
CY2021	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.67
CY2020	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.80
CY2019	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.83
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-326000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1732000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-51000
CY2022	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	481000
CY2021	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	518000
CY2020	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	592000
CY2022	ccap	Income And Excise Taxes IncomeAndExciseTaxes	155000
CY2021	ccap	Income And Excise Taxes IncomeAndExciseTaxes	2250000
CY2020	ccap	Income And Excise Taxes IncomeAndExciseTaxes	541000
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	657000
CY2021Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	1733000
CY2022	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	-911000
CY2021	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	-1177000
CY2020	ccap	Benefit Provision For Taxes On Realized Gain On Investments BenefitProvisionForTaxesOnRealizedGainOnInvestments	46000
CY2022	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	105000
CY2021	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	-220000
CY2020	ccap	Benefit Provision For Taxes On Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnUnrealizedAppreciationDepreciationOnInvestments	-235000
CY2022	ccap	Benefit Provision For Taxes On Realized And Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnRealizedAndUnrealizedAppreciationDepreciationOnInvestments	-806000
CY2021	ccap	Benefit Provision For Taxes On Realized And Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnRealizedAndUnrealizedAppreciationDepreciationOnInvestments	-1397000
CY2020	ccap	Benefit Provision For Taxes On Realized And Unrealized Appreciation Depreciation On Investments BenefitProvisionForTaxesOnRealizedAndUnrealizedAppreciationDepreciationOnInvestments	-189000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	91000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	42000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	899000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	956000
CY2018	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.65
CY2021	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	1.27
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	21.12
CY2022	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-1.43
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	19.88
CY2020	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.18
CY2019	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.14
CY2018	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.89
CY2022	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.50
CY2021	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	2.94
CY2020	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.98
CY2019	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.69
CY2018	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.76
CY2021	ccap	Investment Company Effects Of Rounding Per Share InvestmentCompanyEffectsOfRoundingPerShare	0.01
CY2020	ccap	Investment Company Effects Of Rounding Per Share InvestmentCompanyEffectsOfRoundingPerShare	0.04
CY2019	ccap	Investment Company Effects Of Rounding Per Share InvestmentCompanyEffectsOfRoundingPerShare	0.03
CY2018	ccap	Investment Company Effects Of Rounding Per Share InvestmentCompanyEffectsOfRoundingPerShare	0.06
CY2022	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.79
CY2021	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.69
CY2020	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.64
CY2019	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.64
CY2018	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.47
CY2021	ccap	Investment Company Offering Costs InvestmentCompanyOfferingCosts	-0.02
CY2019	ccap	Investment Company Offering Costs InvestmentCompanyOfferingCosts	-0.01
CY2018	ccap	Investment Company Offering Costs InvestmentCompanyOfferingCosts	-0.02
CY2022	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-1.29
CY2021	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	1.24
CY2020	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.38
CY2019	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.07
CY2018	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.67
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	19.83
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	21.12
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	19.88
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	19.50
CY2018Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	19.43
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	30887360
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	30887360
CY2020Q4	us-gaap	Shares Outstanding SharesOutstanding	20862314
CY2019Q4	us-gaap	Shares Outstanding SharesOutstanding	13358289
CY2018Q4	us-gaap	Shares Outstanding SharesOutstanding	8597116
CY2022Q4	us-gaap	Share Price SharePrice	12.78
CY2021Q4	us-gaap	Share Price SharePrice	17.60
CY2020Q4	us-gaap	Share Price SharePrice	14.57
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30887360
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30887360
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28477771
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28477771
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27681757
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27681757
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17344640
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17344640
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10719485
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10719485
CY2022	ccap	Investment Company Return Based On Market Value InvestmentCompanyReturnBasedOnMarketValue	-0.1845
CY2021	ccap	Investment Company Return Based On Market Value InvestmentCompanyReturnBasedOnMarketValue	0.3246
CY2020	ccap	Investment Company Return Based On Market Value InvestmentCompanyReturnBasedOnMarketValue	0.0147
CY2022	ccap	Investment Company Return Based On Net Asset Value InvestmentCompanyReturnBasedOnNetAssetValue	0.0237
CY2021	ccap	Investment Company Return Based On Net Asset Value InvestmentCompanyReturnBasedOnNetAssetValue	0.1474
CY2020	ccap	Investment Company Return Based On Net Asset Value InvestmentCompanyReturnBasedOnNetAssetValue	0.1036
CY2019	ccap	Investment Company Return Based On Net Asset Value InvestmentCompanyReturnBasedOnNetAssetValue	0.0881
CY2018	ccap	Investment Company Return Based On Net Asset Value InvestmentCompanyReturnBasedOnNetAssetValue	0.0406
CY2022Q4	us-gaap	Assets Net AssetsNet	612541000
CY2021Q4	us-gaap	Assets Net AssetsNet	652285000
CY2020Q4	us-gaap	Assets Net AssetsNet	560000000
CY2019Q4	us-gaap	Assets Net AssetsNet	406917000
CY2018Q4	us-gaap	Assets Net AssetsNet	259579000
CY2022	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.0896
CY2021	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.0781
CY2020	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.0534
CY2019	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.0654
CY2018	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.0733
CY2022	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.0326
CY2021	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.0302
CY2020	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.0224
CY2019	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.0250
CY2018	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.0306
CY2022	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0941
CY2021	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0840
CY2020	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1010
CY2019	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0961
CY2018	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0848
CY2022	ccap	Investment Company Ratio Of Interest And Credit Facility Expenses To Average Net Assets InvestmentCompanyRatioOfInterestAndCreditFacilityExpensesToAverageNetAssets	0.0501
CY2021	ccap	Investment Company Ratio Of Interest And Credit Facility Expenses To Average Net Assets InvestmentCompanyRatioOfInterestAndCreditFacilityExpensesToAverageNetAssets	0.0333
CY2020	ccap	Investment Company Ratio Of Interest And Credit Facility Expenses To Average Net Assets InvestmentCompanyRatioOfInterestAndCreditFacilityExpensesToAverageNetAssets	0.0310
CY2019	ccap	Investment Company Ratio Of Interest And Credit Facility Expenses To Average Net Assets InvestmentCompanyRatioOfInterestAndCreditFacilityExpensesToAverageNetAssets	0.0403
CY2018	ccap	Investment Company Ratio Of Interest And Credit Facility Expenses To Average Net Assets InvestmentCompanyRatioOfInterestAndCreditFacilityExpensesToAverageNetAssets	0.0401
CY2022	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0068
CY2021	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0146
CY2018	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0026
CY2022	ccap	Investment Company Ratio Of Portfolio Turnover InvestmentCompanyRatioOfPortfolioTurnover	0.2152
CY2021	ccap	Investment Company Ratio Of Portfolio Turnover InvestmentCompanyRatioOfPortfolioTurnover	0.4164
CY2020	ccap	Investment Company Ratio Of Portfolio Turnover InvestmentCompanyRatioOfPortfolioTurnover	0.2801
CY2019	ccap	Investment Company Ratio Of Portfolio Turnover InvestmentCompanyRatioOfPortfolioTurnover	0.2397
CY2018	ccap	Investment Company Ratio Of Portfolio Turnover InvestmentCompanyRatioOfPortfolioTurnover	0.2789
CY2022	ccap	Investment Company Asset Coverage Ratio InvestmentCompanyAssetCoverageRatio	1.92
CY2021	ccap	Investment Company Asset Coverage Ratio InvestmentCompanyAssetCoverageRatio	2.01
CY2020	ccap	Investment Company Asset Coverage Ratio InvestmentCompanyAssetCoverageRatio	2.17
CY2019	ccap	Investment Company Asset Coverage Ratio InvestmentCompanyAssetCoverageRatio	2.25
CY2018	ccap	Investment Company Asset Coverage Ratio InvestmentCompanyAssetCoverageRatio	2.09
CY2022Q4	ccap	Asset Coverage Per Unit AssetCoveragePerUnit	1000000

Files In Submission

Name	View Source	Status
0000950170-23-003786-index-headers.html	Edgar Link	pending
0000950170-23-003786-index.html	Edgar Link	pending
0000950170-23-003786.txt	Edgar Link	pending
0000950170-23-003786-xbrl.zip	Edgar Link	pending
ccap-20221231.htm	Edgar Link	pending
ccap-20221231.xsd	Edgar Link	pending
ccap-ex21_1.htm	Edgar Link	pending
ccap-ex23_1.htm	Edgar Link	pending
ccap-ex31_1.htm	Edgar Link	pending
ccap-ex31_2.htm	Edgar Link	pending
ccap-ex32.htm	Edgar Link	pending
ccap-ex4_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img243204539_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
ccap-20221231_cal.xml	Edgar Link	unprocessable
ccap-20221231_def.xml	Edgar Link	unprocessable
ccap-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ccap-20221231_lab.xml	Edgar Link	unprocessable
ccap-20221231_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CCAP
Crescent Capital BDC, Inc. Stock $ccap

2023 Q1 Form 10-K Financial Statement

#000095017023003786 Filed on February 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCAP Crescent Capital BDC, Inc. Stock $ccap

2023 Q1 Form 10-K Financial Statement

#000095017023003786 Filed on February 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCAP
Crescent Capital BDC, Inc. Stock $ccap